Sharemaestro company-news research for Enlivex Therapeutics Ltd (ENLV), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.
NASDAQ
United States
Provisional evidence
Company news sentiment
Latest ENLV news and sentiment
Enlivex Therapeutics Ltd
Company headlines from the last 30 days, weighted by freshness, relevance, publisher quality and the strength of the wording. Price is shown separately.
30-day score50Neutral is 50
Early balanced news score
15/100 evidence confidence
100% direct company focus
3 current stories across 1 publishers
Current company news
Early balanced news score
3 company-specific stories are available, but there are not yet enough fresh stories from separate publishers for a firm reading.
Observed headline tone41/100
→
Published 30-day score50/100
Latest source headline
Enlivex Ltd. (ENLV) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Zacks · 01 Sep 2026 13:55
Older, less relevant and less reliable stories count for less. Confidence is shown separately.
What supports the score
3 current stories are mapped specifically to ENLV.
What limits the score
Only 1 publisher currently contribute to the measured read.
The stories agree, but freshness-weighted evidence is only 0.005.
Confidence is 15/100, below the threshold for a firm score.
50/100
News scoreEarly balanced news score
15/100
Confidencethin evidence
100%/100
Company news3 company stories
100/100
Story agreement0/100 difference
News history
Daily score and story count over 30 days
22 Aug06 Sep20 Sep
News scoreStory count50 baseline
Confidence
How reliable the score is
Confidence uses the amount of news, separate publishers, direct company relevance, freshness and agreement. A high or low score is not automatically reliable.
Amount of evidence0
0.005 after freshness weightingSource breadth20
1 independent publishersCompany relevance100
share tied directly to this companyFreshness1
recency-weighted evidenceAgreement100
how closely stories agreePublisher mix0
less reliance on one publisherPrice and news history
Weekly price and news-score history
Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal.
26 completed price weeks13 comparable news-score weeks
One scoring method across the chart.Stored company headlines are recalculated at each weekly point with the current 30-day freshness weighting. Old published snapshots are left unchanged.
27 Mar23 Jun18 Sep
Weekly close, indexedSentiment score
WeekNews scoreCloseWeekly move
18 Sep 202650USD 0.8066-15.9%
11 Sep 202650USD 0.9595-12.8%
04 Sep 202650USD 1.1-18.5%
28 Aug 202649USD 1.35-8.2%
21 Aug 202650USD 1.47-7.0%
14 Aug 202651USD 1.58-24.0%
07 Aug 202653USD 2.08-0.5%
31 Jul 202648USD 2.09-50.2%
Provisional evidence
News subjects
What is shaping the score
Market update502 stories · 67%
Earnings411 stories · 33%
Source mix
Where the evidence comes from
TradingView411 stories · 33%
Zacks501 stories · 33%
Kalkine501 stories · 33%
Recurring subjects
Subjects appearing most often
Life Sciences1Earnings1
Earlier readings
How the score has changed
Past and present use the same method.Each point recalculates the previous 30 days of stored company headlines with today's scoring rules. The original stored snapshots remain unchanged.
22 Jun50 neutral20 Sep 07:22
ConstructiveBalanced or withheldCautious
Changes in the stored score
Scores are rebuilt from stored headlines with the current 30-day method. Days with no change are collapsed.
| Observed | Score | Move | Confidence | Stories | Status |
|---|---|---|---|---|---|
| 20 Sep 07:22 | 50 | +0 | 14/100 (-6) | 3 (-8) | Provisional |
| 01 Sep 23:59 | 50 | +0 | 20/100 (-3) | 11 (+1) | Provisional |
| 29 Aug 23:59 | 50 | +1 | 23/100 (-5) | 10 (-14) | Provisional |
| 25 Aug 23:59 | 49 | -2 | 28/100 (+7) | 24 (-8) | Provisional |
| 14 Aug 23:59 | 51 | +0 | 21/100 (0) | 32 (+1) | Provisional |
| 13 Aug 23:59 | 51 | -1 | 21/100 (-3) | 31 (+1) | Provisional |
| 11 Aug 23:59 | 52 | -1 | 24/100 (-5) | 30 (0) | Provisional |
| 08 Aug 23:59 | 53 | -1 | 29/100 (+2) | 30 (+1) | Provisional |
Source headlines
The news behind the score
Only company-specific stories enter this score. The latest 30 days are shown newest first, with newer stories weighted more heavily and duplicate coverage combined.
#1—Not directional
ZacksDirect company coverageScored from headline
Enlivex Ltd. (ENLV) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
- Published
- 01 Sep 2026 13:55
- News subject
- Market update
- Why this score
- The headline reports news without a clear direction
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 17.4d old
- Duplicates
- 1 consolidated
#2—Not directional
KalkineDirect company coverageScored from headline
Enlivex Therapeutics Ltd (NASDAQ: ENLV) Stock Price, News & Analysis
- Published
- 29 Aug 2026 02:14
- News subject
- Market update
- Why this score
- The headline reports news without a clear direction
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 20.9d old
- Duplicates
- 1 consolidated
#341Tone
TradingViewDirect company coverageStored article
Enlivex Ltd expected to post a loss of 31 cents a share - Earnings Preview
Enlivex Ltd is anticipated to report an earnings loss of 31 cents per share. This information comes from an earnings preview, and the full article is available through a subscription service on TradingView.
EarningsLife Sciences
- Published
- 25 Aug 2026 19:45
- News subject
- Earnings
- Why this score
- Negative financial language
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Story strength
- Medium · 37/100
- 30-day weight
- 100% of the score · 24.1d old
- Duplicates
- 1 consolidated
Earlier company news
ENLV news archive
Stored newest first for historical research. It starts after the newest three pages above and then continues through older news. Each archive page is loaded only when it is opened.
Older news is kept in the archive
There are 44 older ENLV headlines. Open one page at a time when you need them.
Open older archiveProvider matches checked
Provider mentions not used in the score
A news provider linked these stories to ENLV, but the headline and available text are not mainly about Enlivex Therapeutics Ltd. They are kept here for transparency and do not affect the score, confidence, history or wider market totals.
Provider mentions are kept separate
Open the list to see which provider matches were checked and left out of ENLV sentiment.
Open provider mentionsHow the page works
How to read the score
It describes the weighted balance of qualifying headlines. A score of 50 can mean balanced news or that there is not enough evidence; the status label explains which.
Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.
Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.
It measures news already published. It is not a forecast, recommendation or price target.